Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Professor of Pharmacology in Critical Care Medicine



+44 (0)20 7351 8137j.a.mitchell




Guy Scadding BuildingRoyal Brompton Campus





Jane Mitchell is Head of the Vascular Biology research group at NHLI. Professor Mitchell is a stream lead for the taught MSc course: Genes, Drugs and Stem Cells.

Professor Mitchell completed a PhD in Pharmacology with Sir Professor John R Vane (FRS, Nobel Laureate) and Dr Gilberto De Nucci 1990 before joining Professor Ferid Murad (NAS USA, Nobel Laureate) as a fellow of Northwestern University (Chicago, USA) for her postdoctoral training in the biochemistry of nitric oxide synthase. She returned to work with John Vane on the pharmacology of cyclo-oxygenase isoforms before joining the group of Professor Timothy Williams at the National Heart and Lung Institute, now part of Imperial College.

Professor Mitchell was awarded a Wellcome Trust Career Development Fellowship in 1997 and the Novartis Prize for Pharmacology in 1999 for her contribution to the field of cyclo-oxygeanse biology. Since this time, Professor Mitchell has led her own group - Cardiothoracic Pharmacology - consisting of academics, clinicians, postdoctoral fellows and undergraduate/postgraduate students.

Professor Mitchell is amongst the top 1% of cited pharmacologists world-wide and as such, is a member of Thomson Scientific Highlycited listings ( with more than 150 publications in peer reviewed journals.

Professor Mitchell was awarded the 2009 Rector’s Award for Excellence in Research Supervision and Elected Research Supervision Fellow.

Professor Mitchell was awarded the AstraZeneca Women in Pharmacology Prize in 2012.  She talks about receiving the award here.



Ahmetaj-Shala B, Kawai R, Marei I, et al., 2019, A bioassay system of autologous human endothelial and smooth muscle cells for use in cardiovascular drug discovery and patient phenotyping, British-Pharmacology-Society Meeting (Pharmacology), WILEY, Pages:3040-3041, ISSN:0007-1188

Mohamed NA, Davies RP, Lickiss PD, et al., 2019, Mil-89 nanoformulation as a platform to improve pulmonary arterial hypertension treatment, British-Pharmacology-Society Meeting (Pharmacology), WILEY, Pages:3075-3075, ISSN:0007-1188

Marei I, Mongey R, Gashaw H, et al., 2019, Isolation of blood outgrowth endothelial cells under shear conditions: A move towards a more physiological vascular cell platform, British-Pharmacology-Society Meeting (Pharmacology), WILEY, Pages:3033-3033, ISSN:0007-1188

Marei I, Al Shammari H, Latif N, et al., 2019, Effect of toll-like receptor antagonists on side specific aortic valve endothelial cells, British-Pharmacology-Society Meeting (Pharmacology), WILEY, Pages:2999-3000, ISSN:0007-1188

Mazi SI, Ahmetaj-Shala B, Warner TD, et al., 2019, Omic profiling in healthy volunteers taking celecoxib reveals novel biomarkers regulated by cyclooxygenase-2, British-Pharmacology-Society Meeting (Pharmacology), WILEY, Pages:1628-1628, ISSN:0306-5251

More Publications